Search Login Register
lansoprazole
(Prevacid)
Summary
Description:
K+/H+-ATPase antagonist; dexlansoprazole (TAK-390MR) is the enantiomer; structure given in first source
Also Known As:
Prevacid; 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole; AG 1749; AG-1749; Abbot Brand of Lansoprazole Show All >>
Networked: 807
relevant articles (168 outcomes,
194 trials/studies)
for this Drug
Key Diseases for which lansoprazole is
Relevant
-
Gastroesophageal Reflux (GERD)
:
31 outcomes 42 studies in 142 results
-
Duodenal Ulcer (Curling's Ulcer)
:
28 outcomes 27 studies in 103 results
-
Heartburn (Pyrosis)
:
22 outcomes 11 studies in 68 results
-
Infection
:
19 outcomes 16 studies in 132 results
-
Ulcer
:
18 outcomes 24 studies in 127 results
Show All >>
Drugs Related to lansoprazole
-
Omeprazole (Esomeprazole)
-
Ranitidine (Zantac)
-
Amoxicillin (Wymox)
-
Clarithromycin (Biaxin)
-
Proton Pumps (Proton Pump)
-
pantoprazole (Protonix)
-
Proton Pump Inhibitors
-
lansoprazole (Prevacid)
-
Famotidine (Pepcid)
-
rabeprazole (Aciphex)
Show All >>
Therapies Related to lansoprazole
-
Aftercare (After-Treatment)
-
Fundoplication
-
Drug-Eluting Stents
-
Withholding Treatment
-
Ligation
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.